CENPA expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.989600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.386800E-01
Normal-vs-Stage2
3.608600E-01
Normal-vs-Stage3
8.003600E-01
Normal-vs-Stage4
6.239800E-01
Stage1-vs-Stage2
3.472000E-01
Stage1-vs-Stage3
8.783400E-01
Stage1-vs-Stage4
8.095000E-01
Stage2-vs-Stage3
3.753200E-01
Stage2-vs-Stage4
5.809600E-01
Stage3-vs-Stage4
7.104000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.955600E-01
Normal-vs-AfricanAmerican
5.240400E-01
Normal-vs-Asian
2.516200E-01
Caucasian-vs-AfricanAmerican
8.663600E-01
Caucasian-vs-Asian
6.154600E-01
AfricanAmerican-vs-Asian
9.541600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.465200E-01
Normal-vs-Female
4.382800E-01
Male-vs-Female
5.622200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.147400E-01
Normal-vs-Age(41-60Yrs)
4.184200E-01
Normal-vs-Age(61-80Yrs)
3.765800E-01
Normal-vs-Age(81-100Yrs)
2.883000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.708400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.570400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.776800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.048200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.835800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.762000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.749400E-01
Normal-vs-Daily Drinker
3.178800E-01
Normal-vs-Weekly Drinker
5.143000E-01
Normal-vs-Occasional Drinker
2.623800E-01
Normal-vs-Social Drinker
3.742200E-01
Non Drinker-vs-Daily Drinker
8.458000E-01
Non Drinker-vs-Weekly Drinker
5.759800E-01
Non Drinker-vs-Occasional Drinker
6.844000E-01
Non Drinker-vs-Social Drinker
8.329800E-01
Daily Drinker-vs-Weekly Drinker
6.376600E-01
Daily Drinker-vs-Occasional Drinker
8.299800E-01
Daily Drinker-vs-Social Drinker
9.645800E-01
Weekly Drinker-vs-Occasional Drinker
7.139800E-01
Weekly Drinker-vs-Social Drinker
6.682000E-01
Occasional Drinker-vs-Social Drinker
8.881400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.391400E-01
Normal-vs-Grade 2
5.762600E-01
Normal-vs-Grade 3
5.993000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.676400E-03
Grade 1-vs-Grade 3
3.171700E-04
Grade 1-vs-Grade 4
5.391400E-01
Grade 2-vs-Grade 3
1.034190E-01
Grade 2-vs-Grade 4
5.762600E-01
Grade 3-vs-Grade 4
5.993000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.662400E-01
Normal-vs-NonDiabetic
3.844800E-01
Diabetic-vs-NonDiabetic
3.596400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.823420E-01
Normal-vs-NoPancreatitis
4.303000E-01
Pancreatitis-vs-NoPancreatitis
5.146400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.067000E-01
Normal-vs-N1
3.684200E-01
N0-vs-N1
1.671200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.400810E-01
Normal-vs-TP53-NonMutant
5.810000E-01
TP53-Mutant-vs-TP53-NonMutant
3.39339999999577E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
